A Modified Minimally Invasive Approach Towards Le Fort I Osteotomy: a Prospective Study
NCT ID: NCT02660216
Last Updated: 2021-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2014-11-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to present and validate a minimally invasive approach towards Le Fort I osteotomy, using a modified pterygomaxillary (PTM) disjunction technique. The primary outcome is to evaluate the accuracy of the technique using rigid voxel-based registration of the 3D virtual treatment planning and the 4 weeks postoperative CBCT images. Secondary outcomes include the surgical time necessary to complete the procedure and the presence of intraoperative and early postoperative complications.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A New Surgical Approach to Treat Medial or Low Condylar Fractures
NCT01851031
Surgical Management of Posterior Tibial Plateau Fractures
NCT03540719
Management of Closed Diaphyseal Displaced Leg Fractures in Children and Adolescents
NCT06503718
Open Versus Endoscopic Surgery of Craniomaxillofacial (CMF) Condylar Neck Fractures
NCT00206011
The Nasal Changes Affected by Different Alar Base Suture Techniques After Maxillary LeFort I Osteotomy
NCT01473745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients of all genders
* A Le Fort I osteotomy is planned, as part of a bimaxillary orthognathic procedure
* The surgery is planned with 3D Virtual Treatment Planning (Maxilim v. 2.3.0.3.0.)
* The planning is transferred with 3D CAD/CAM tooth-borne splint and vertical internal bony reference landmarks
* The maxilla is repositioned first during the surgery (maxilla first sequence)
Exclusion Criteria
* Simultaneous extraction of impacted teeth 18 and/or 28
* Previous maxillary orthognathic surgery
* Previous Surgical Assisted Rapid Palatal Expansion (SARPE)
* Syndromic condition, including cleft lip and palate
* Segmental Le Fort I osteotomy
* Adjuvant Zygomatic osteotomy
* Maxillary impaction higher than 3 mm
* Maxillary advancement greater than 5 mm
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AZ Sint-Jan AV
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gwen Swennen
Maxillofacial Surgeon, MD, LDS, DMD, PhD, FEBOMFS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gwen Swennen
Role: PRINCIPAL_INVESTIGATOR
Division of Maxillofacial Surgery, Department of Surgery, General Hospital Saint-John Bruges, Belgium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
general hospital Saint-John Bruges
Bruges, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BO49201525495
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.